We serve Chemical Name:3-Ethynylphenol CAS:10401-11-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-Ethynylphenol
CAS.NO:10401-11-3
Synonyms:MFCD00078287;3-Ethynylphenol;m-ethynylphenol;Phenol, 3-ethynyl-
Molecular Formula:C8H6O
Molecular Weight:118.133
HS Code:2907199090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:230.9±23.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.590
PSA:20.23000
Exact Mass:118.041862
LogP:1.66
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:2810
Packing Group:
Contact us for information like MFCD00078287 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Phenol, 3-ethynyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,m-ethynylphenol Use and application,m-ethynylphenol technical grade,usp/ep/jp grade.
Related News: Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry. 3-Ethynylphenol manufacturer Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined. 3-Ethynylphenol supplier Alira is one of many in the CRO space to ink deals in recent months. Altasciences acquired preclinical CRO Calvert Laboratories in May, weeks after itself being bought out by Novo Holdings, and a few months after buying early-stage CRO WCCT Global. 3-Ethynylphenol vendor Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities. 3-Ethynylphenol factory Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development.
